(VIANEWS) - Hercules Technology Growth Capital (HTGC), ProLogis (PLD), MetLife (MET) are the highest payout ratio stocks on this list.
Here's the data we've collected of stocks with a high payout ratio up to now. The payout ratio in itself isn't a guarantee of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Hercules Technology Growth Capital (HTGC)
451.52% Payout Ratio
Earnings per Share
Hercules Technology Growth Capital's trailing 12 months EPS is $0.33.
PE Ratio
Hercules Technology Growth Capital's trailing 12-month price-to-earnings ratio is 41.31. The purchaser of the shares is therefore investing $41.31 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 3.2%.Growth Estimates Quarters
For the current quarter, the company expects to grow by 20% and 40% respectively.2. ProLogis (PLD)
56.8% Payout Ratio
Prologis, Inc., is the world's leader in logistics real property with a special focus on high growth, high-barrier markets. The company had invested in or owned properties or development projects in approximately 984,000,000 square feet in 19 countries as of December 31, 2020. Prologis leases logistics infrastructure to approximately 5,500 clients, primarily in two main categories: business-to–business and retail/online fulfillment.
Earnings per Share
ProLogis' trailing twelve-month EPS is $1.82.
PE Ratio
ProLogis' trailing 12-month price-earnings ratio is 62.72. The purchaser of the shares is therefore investing $62.72 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 11.1%.Moving Average
ProLogis's value exceeds its 50-day moving mean of $109.48, and is significantly lower than its 200-day moving mean of $128.63.Revenue Growth
Year-on-year quarterly revenue growth grew by 44%, now sitting on 5.91B for the twelve trailing months.
3. MetLife (MET)
49.08% Payout Ratio
MetLife, Inc., is a financial service company that provides annuities, benefits for employees, and investment services. The company operates in five regions: the U.S., Asia, Latin America and Europe; Europe and the Middle East and Africa; as well as MetLife Holdings. It offers individual, short- and long-term disability insurance as well life and dental plans. The company also offers pension risk transfer, institution income annuities and structured settlements. It also sells capital markets investment products. It also offers fixed, index-linked and variable annuities, as well as pension products, regular savings products, whole and term, endowments and universal life and group products, longevity reinsurance products, credit insurance products, and protection against long-term healthcare services. MetLife, Inc. is an American insurance company based in New York, New York.
Earnings Per Share
As for profitability, MetLife has a trailing twelve months EPS of $5.68.
PE Ratio
MetLife has a trailing twelve months price to earnings ratio of 12.72. Meaning, the purchaser of the share is investing $12.72 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.76%.Volume
Today's last reported volume for MetLife is 1233690 which is 70.51% below its average volume of 4183810.
Moving Average
MetLife's value is above its 50-day moving average of $72.11 and higher than its 200-day moving average of $67.03.Sales Growth
MetLife sales growth was 26.4% in the current quarter, and negative 14.1% the following.
4. Simulations Plus (SLP)
40% Payout Ratio
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.
Earnings Per Share
As for profitability, Simulations Plus has a trailing twelve months EPS of $0.6.
PE Ratio
Simulations Plus has a trailing twelve months price to earnings ratio of 63.27. Meaning, the purchaser of the share is investing $63.27 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.26%.Sales Growth
Simulations Plus's sales growth is negative 0.5% for the present quarter and 10.4% for the next.
Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is a negative 46.7% and a negative 14.3%, respectively.Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Oct 27, 2022, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 0.63%.
5. Yum! (YUM)
37.64% Payout Ratio
YUM! Brands, Inc., along with its subsidiaries, creates, manages, and franchises fast-food restaurants around the world. The company operates in four divisions: KFC Division; Taco Bell Division; Pizza Hut Division; and Habit Burger Grill Division. The restaurant chain operates under The Habit Burger Grill, Pizza Hut and Taco Bell brands. These restaurants specialize in Mexican food, chicken, pizza and made-to order chargrilled hamburgers. It had approximately 26934 KFC and 18,381 Pizza Hut and 7,791 Taco Bell restaurants. There were also 318 Habit Burger Grill locations in 157 countries. YUM! was formerly TRICON Global restaurants, Inc. Brands, Inc. was established in May 2002. YUM! Brands, Inc. was founded in 1997. It is located in Louisville, Kentucky.
Earnings per Share
Yum! is profitable. Yum! has an EPS trailing twelve months of $3.74
PE Ratio
Yum! Trailing 12-month earnings to price ratio is 34.5 The purchaser of the shares is investing $34.5 per dollar in annual earnings.
Moving Average
Yum!'s value is way above its 50-day moving average of $112.26 and way above its 200-day moving average of $116.85.Dividend Yield
Morningstar, Inc. claims that the next dividend payment will be made on May 25, 2022. The forward dividend rate and yield are both 2.28 and 1.86%, respectively.